Literature DB >> 15708450

Beta-amyloid deposition and tau phosphorylation in clinically characterized aged cats.

E Head1, K Moffat, P Das, F Sarsoza, W W Poon, G Landsberg, Carl W Cotman, M P Murphy.   

Abstract

The current study describes both Abeta and tau abnormalities that accumulate in the brains of aged (16-21 years), but not young (<4 years) clinically characterized cats. Diffuse plaques that were morphologically different from what is typically observed in the human brain could be detected with 4G8 (Abeta17-24) or an Abeta1-42-specific antibody but not with N-terminal Abeta or an Abeta1-40-specific antibody. SELDI-TOF mass spectrometry experiments indicated that cat brain Abeta consisted almost entirely of Abeta1-42. Markers of tau hyperphosphorylation (AT8 and PHF-1) labeled a subset of neurons in two aged animals. In the hilus of the hippocampus, a subset of AT8 positive neurons showed a sprouting morphology similar to that observed in human brain. Western blot analysis with antibodies against hyperphosphorylated tau indicated that tau is hyperphosphorylated in the aged cat and contains many of the same epitopes found in Alzheimer's disease (AD) brain. Thus, the aged cat brain develops AD-related lesions with important morphological and biochemical differences compared to human brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708450     DOI: 10.1016/j.neurobiolaging.2004.06.015

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  20 in total

Review 1.  Animal models in the drug discovery pipeline for Alzheimer's disease.

Authors:  Debby Van Dam; Peter Paul De Deyn
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

2.  Feline bone marrow-derived mesenchymal stromal cells (MSCs) show similar phenotype and functions with regards to neuronal differentiation as human MSCs.

Authors:  Jessian L Munoz; Steven J Greco; Shyam A Patel; Lauren S Sherman; Suresh Bhatt; Rekha S Bhatt; Jeffrey A Shrensel; Yan-Zhong Guan; Guiqin Xie; Jiang-Hong Ye; Pranela Rameshwar; Allan Siegel
Journal:  Differentiation       Date:  2012-07-21       Impact factor: 3.880

Review 3.  Aging in the canine and feline brain.

Authors:  Charles H Vite; Elizabeth Head
Journal:  Vet Clin North Am Small Anim Pract       Date:  2014-11-01       Impact factor: 2.093

4.  β-amyloid and tau pathology in the aging feline brain.

Authors:  Kimberly L Fiock; Jodi D Smith; John F Crary; Marco M Hefti
Journal:  J Comp Neurol       Date:  2019-07-12       Impact factor: 3.215

5.  HIV and FIV glycoproteins increase cellular tau pathology via cGMP-dependent kinase II activation.

Authors:  Matheus F Sathler; Michael J Doolittle; James A Cockrell; India R Nadalin; Franz Hofmann; Sue VandeWoude; Seonil Kim
Journal:  J Cell Sci       Date:  2022-06-21       Impact factor: 5.235

6.  Neuropathology of Aging in Cats and its Similarities to Human Alzheimer's Disease.

Authors:  Lorena Sordo; Alessandra C Martini; E Fiona Houston; Elizabeth Head; Danièlle Gunn-Moore
Journal:  Front Aging       Date:  2021-06-07

7.  Alzheimer's disease and natural cognitive aging may represent adaptive metabolism reduction programs.

Authors:  Jared Edward Reser
Journal:  Behav Brain Funct       Date:  2009-02-28       Impact factor: 3.759

8.  The domestic cat as a natural animal model of Alzheimer's disease.

Authors:  James K Chambers; Takahiko Tokuda; Kazuyuki Uchida; Ryotaro Ishii; Harutsugu Tatebe; Erika Takahashi; Takami Tomiyama; Yumi Une; Hiroyuki Nakayama
Journal:  Acta Neuropathol Commun       Date:  2015-12-10       Impact factor: 7.801

Review 9.  Prevention approaches in a preclinical canine model of Alzheimer's disease: benefits and challenges.

Authors:  Paulina R Davis; Elizabeth Head
Journal:  Front Pharmacol       Date:  2014-03-21       Impact factor: 5.810

10.  Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment.

Authors:  J R Walton
Journal:  Int J Alzheimers Dis       Date:  2012-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.